These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2243434)

  • 21. Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia.
    Ketomäki A; Gylling H; Siimes MA; Vuorio A; Miettinen TA
    Pediatr Res; 2003 Apr; 53(4):648-53. PubMed ID: 12612218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
    Parthasarathy S; Steinberg D; Witztum JL
    Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E
    Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells.
    Norata GD; Raselli S; Grigore L; Garlaschelli K; Vianello D; Bertocco S; Zambon A; Catapano AL
    Atherosclerosis; 2009 Oct; 206(2):556-62. PubMed ID: 19376517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.
    Geiss HC; Otto C; Hund-Wissner E; Parhofer KG
    Atherosclerosis; 2005 May; 180(1):107-12. PubMed ID: 15823282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
    Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
    Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
    Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
    Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipoprotein-mediated cellular mechanisms for atherogenesis in hypertriglyceridemia.
    Gianturco SH; Bradley WA
    Semin Thromb Hemost; 1988 Apr; 14(2):165-9. PubMed ID: 3061002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1).
    Matthews AJ; Vercellotti GM; Menchaca HJ; Bloch PH; Michalek VN; Marker PH; Murar J; Buchwald H
    J Surg Res; 1997 Nov; 73(1):35-40. PubMed ID: 9441790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of modification of lipoproteins and of the immune system in early atherogenesis.
    Mol MJ; Demacker PN; Stalenhoef AF
    Neth J Med; 1993 Aug; 43(1-2):83-90. PubMed ID: 8232700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis.
    Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis and properties of an affinity sorbent for extraction of atherogenic lipoproteins].
    Andrianova IP; Rabovskiĭ AB; Zuevskiĭ VV; Tsybul'skaia MV; Samoĭlova NA
    Bioorg Khim; 1986 Oct; 12(10):1391-5. PubMed ID: 3468950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [How does endogenous and exogenous cholesterol influence the lipoprotein metabolism. Effects of long-term endurance exercise, and accumulation of cholesterol ester on the aortic wall].
    Terao T; Miyoshi M; Yoshioka T; Nakano S
    Nihon Seirigaku Zasshi; 1985; 47(3):130-40. PubMed ID: 4032319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of cholesterol concept of atherogenesis from Anitchkov to our days.
    Klimov AN; Nagornev VA
    Pediatr Pathol Mol Med; 2002; 21(3):307-20. PubMed ID: 12056505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonoxidative modifications of lipoproteins in atherogenesis.
    Tabas I
    Annu Rev Nutr; 1999; 19():123-39. PubMed ID: 10448519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retention of atherogenic lipoproteins in atherogenesis.
    Gustafsson M; Flood C; Jirholt P; Borén J
    Cell Mol Life Sci; 2004 Jan; 61(1):4-9. PubMed ID: 14704849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of plasma lipoproteins by group IIA phospholipase A(2): possible implications for atherogenesis.
    Sartipy P; Hurt-Camejo E
    Trends Cardiovasc Med; 1999 Nov; 9(8):232-8. PubMed ID: 11094331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia.
    Steinberg D
    J Lipid Res; 2005 Oct; 46(10):2037-51. PubMed ID: 15995167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remnant lipoproteins and atherogenesis.
    Kawakami A; Yoshida M; Tanaka A; Nakajima K; Yasukochi Y; Shimokado K; Numano F
    Ann N Y Acad Sci; 2001 Dec; 947():366-9. PubMed ID: 11795292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.